1Gooderham M J, Bolli P, Fernandez P G. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin[J]. Ann Pharmacother, 1999, 33 (7-8) : 796-799.
2Isogai H, Isogai E, Hayashi S, et al. Experimental Helicobacter pylori infection in association with other bacteria[J]. Microbiol Immunol, 1997, 41(4): 361-365.
3Aiba Y, Suzuki N, Kabir A M, et al. Lactic acid-mediated suppression of Helieobaeter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model[J]. Am J Gastroenterol, 1998,93(11): 2097-2101.
4Kabir A M, Aiba Y, Takagi A, et al. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic routine model[J]. Gut, 1997,41(1): 49-55.
5Sakamoto I, Igarashi M, Kimura K, et al. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans [ J ]. J Antimicrob Chemother,2001,47(5) : 709-710.
6Canducci F, Armuzzi A, Cremonini F, et al. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helienbacter pylori eradication rates [J]. Aliment Pharmacol Ther, 2000, 14(12): 1625-1629.
7Yuki N, Shimazaki T, Kushiro A, et al. Colonization of the stratified squamous epithelium of the nonsecreting area of horse stomach by lactohacilli [J]. Appl Environ Microhiol,2000,66(11): 5030-5034.
8Bomba A, Kastel R, Gancarclkova S,et al. The effect of lactobacilli inoculation on organic acid levels in the mucosal film and the small intestine contents in gnotobiotic pigs[J].Berl Munch Tierarztl Wochenschr, 1996, 109 (11-12) : 428-430.
9Rolfe R D. The role of probiotic cultures in the control of gastrointestinal health [J]. J Nutr, 2000, 130 (2S Suppl) : 396S-402S.
10Midolo P D, Lambert J R, Hull R, et al. In vitro inhibition of Helicobacter pylori NCTC 11837 by organic acids and lactic acid bacteria[J]. J Appl Bacteriol, 1995,79(4): 475-479.
